ACLY and non-small cell lung carcinoma: Molecular or biochemical blockade of ACLY suppresses DNL and inhibits NSCLC cell growth [41, 43, 44], and combined inhibition of ACLY and HMGR by lovastatin enhanced the anti-proliferative effects of ACLY inhibition.